Suchergebnisse - "Castagna, Antonella"

PubPharm (34)

1

Cohort profile : PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors

enthalten in: BMJ open | 2024

von Clemente, T. | Galli, L. | Lolatto, R. | +17

2

Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting

enthalten in: International journal of antimicrobial agents | 2023

von Clemente, T. | Galli, L. | Poli, A. | +9

3

Evaluation of HIV-DNA and residual viremia levels through week 96 in HIV-infected individuals who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor-based regimen

enthalten in: International journal of antimicrobial agents | 2023

von Scutari, R. | Galli, L. | Alteri, C. | +9

4

Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry

enthalten in: International journal of antimicrobial agents | 2023

von Saladini, F. | Giammarino, F. | Maggiolo, F. | +12

5

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium

enthalten in: HIV medicine | 2022

von Byonanebye, D. | Polizzotto, M. | Neesgaard, B. | +90

6

Achieving virological control in pan-resistant HIV-1 infection : A case series

enthalten in: EBioMedicine | 2022

von Canetti, D. | Muccini, C. | Spagnuolo, V. | +5

7

Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice

enthalten in: Drug design, development and therapy | 2022

von Ranzenigo, M. | Gianotti, N. | Galli, L. | +12

ErratumIn: Drug Des Devel Ther. 2022 Oct 27;16:3737-3738. - PMID 36310663

8

Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database

enthalten in: International journal of antimicrobial agents | 2021

von Lombardi, F. | Giacomelli, A. | Armenia, D. | +14

9

Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients

enthalten in: International journal of antimicrobial agents | 2020

von Galizzi, N. | Poli, A. | Galli, L. | +9

10

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting : The RESPOND cohort consortium

enthalten in: PloS one | 2020

von Neesgaard, B. | Mocroft, A. | Zangerle, R. | +33